APA (7th ed.) Citation

L, P., A, L., C, B., B, X., P, G., R, P. L., . . . V, G. (2023). Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors. Cancers, 15(4), . https://doi.org/10.3390/cancers15041045

Chicago Style (17th ed.) Citation

L, Pérez-Lamas, et al. "Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors." Cancers 15, no. 4 (2023). https://doi.org/10.3390/cancers15041045.

MLA (9th ed.) Citation

L, Pérez-Lamas, et al. "Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors." Cancers, vol. 15, no. 4, 2023, https://doi.org/10.3390/cancers15041045.